Gene Therapy Targets Chronic Pain
Scientists at New York University have developed a gene therapy [...]
AusperBio Announces FDA Clearance of IND Application of AHB-137 in Chronic Hepatitis B Treatment
“The FDA’s clearance of our IND application to initiate clinical [...]
Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking Approval of RYBREVANT® (amivantamab-vmjw) in Combination with Chemotherapy for the First-line Treatment of Patients with Locally Advanced or Metastatic EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
“PAPILLON is the first randomized Phase 3 study in patients [...]
First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial
Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “Results from cohort 2 [...]
First Cancer Patient Treated Using RefleXion’s Scintix Radiotherapy
The RefleXion X1 PET-CT machine with Scintix therapy is a [...]
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
Exclusive agreement for AI algorithms to accelerate earlier detection of [...]
The Supply and Availability of Radiopharmaceuticals
These medical isotope-fueled compounds are being used for the diagnosis [...]
Medtronic’s Renal Denervation Dreams Dashed Again
An advisory committee voted against Medtronic's renal denervation system on [...]
Philips Integrates AI in Cardiac Ultrasound and Across Cardiac Care at ESC 2023
Integrating AI in cardiac ultrasound – Ultrasound is one of [...]
EU MDR Is the New FDA PMA
A new CE mark for an oxygen machine serves as [...]